Escape from targeted inhibition: the dark side of kinase inhibitor therapy.
Wykosky
Jill
J
Ludwig Institute for Cancer Research, University of California San Diego, La Jolla, CA, USA.
Mukasa
Akitake
A
Furnari
Frank
F
Cavenee
Webster K
WK
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018797:Cell Cycle Proteins / Q000378:metabolism; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D018797:Cell Cycle Proteins; D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors